Publications
2017
30/11/2017
Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
30/01/2017
Analysis of Reproducibility of Proteome Coverage and Quantitation Using Isobaric Mass Tags (iTRAQ and TMT)
Read →
05/01/2017
Comprehensive Mass Spectrometry Based Biomarker and Validation Platform as Applied to Diabetic Kidney Disease
Read →
2015
29/09/2015
US Patent – Methods of Assessing Diabetic Nephropathy Using CD5 Antigen-Like
Read →
Newsroom
In the Media
Presentations
Newsletters
Publications
Events
Categories
Biomarker Discovery
Drug Discovery
iTRAQ
Method Development
Patents
Proteogenomics
Proteomics
1
2
3
4
5
6
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Comments
This field is for validation purposes and should be left unchanged.
This iframe contains the logic required to handle Ajax powered Gravity Forms.
Company
About Us
Board
Senior Staff
Quality
Customer Testimonials
Careers
Glossary
PromarkerD
Diagnostics
Biomarker Discovery
Analytical Services
Pharmacokinetic Testing
Biosimilars/Biologics Drug Characterisation
Proteome Mapping
Protein Quantitation (iTRAQ)
Targeted Mass Spectrometry (MRM/SRM)
Protein ID by Mass Spectrometry
Post-translational Modifications (PTMs)
Additional Services
Project Consultation
Pricing and Ordering
Terms and Conditions
Peptide Drug Discovery
FAQs
Newsroom
Media Releases
Media Coverage
Media Contact
Newsletters
Publications
Events
Investors
Share Price and Analyst Coverage
ASX Announcements
Corporate Video
Corporate Presentations
Reports
Corporate Governance
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents
